Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RP105 is a B-cell surface molecule that has been recently assigned as CD180. RP105 ligation with an antibody induces B-cell activation in humans and mice, leading to proliferation and up-regulation of a costimulatory molecule, B7.2/CD86. RP105 is associated with an extracellular molecule, MD-1. RP105/MD-1 has structural similarity to Toll-like receptor 4 (TLR4)/
MD-2
. TLR4 signals a membrane constituent of Gram-negative bacteria,
lipopolysaccharide
(
LPS
).
MD-2
is indispensable for TLR4-dependent
LPS
responses because cells expressing TLR4/
MD-2
, but not TLR4 alone, respond to
LPS
. RP105 also has a role in
LPS
responses because B cells lacking RP105 show hyporesponsiveness to
LPS
. Little is known, however, regarding whether MD-1 is important for RP105-dependent
LPS
responses, as
MD-2
is for TLR4. To address the issue, we developed mice lacking MD-1 and generated monoclonal antibodies (mAbs) to the protein. MD-1-null mice showed impairment in
LPS
-induced B-cell proliferation, antibody production, and B7.2/CD86 up-regulation. These phenotypes are similar to those of RP105-null mice. The similarity was attributed to the absence of cell surface RP105 on MD-1-null B cells. MD-1 is indispensable for cell surface expression of RP105. A role for MD-1 in
LPS
responses was further studied with anti-mouse MD-1 mAbs. In contrast to highly mitogenic anti-RP105 mAbs, the mAbs to MD-1 were not mitogenic but antagonistic on
LPS
-induced B-cell proliferation and on B7.2 up-regulation. Collectively, MD-1 is important for RP105 with respect to B-cell surface expression and
LPS
recognition and signaling.
...
PMID:Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. 1186 Dec 86
The normal intestinal epithelium is not inflamed despite contact with a high density of commensal bacteria. Intestinal epithelial cells (IEC) express low levels of TLR4 and
MD-2
and are
lipopolysaccharide
(
LPS
)-unresponsive. We hypothesized that immune-mediated signals regulate the expression of TLR4 and
MD-2
in IEC. Expression of TLR4 and
MD-2
was examined in normal colonic epithelial cells or intestinal epithelial cell lines. The effect of the cytokines interferon (IFN)-gamma, IFN-alpha, and tumor necrosis factor-alpha (TNF-alpha) on TLR4 and
MD-2
expression was examined by reverse transcription-PCR and Western blot. NF-kappaB transcriptional activation and interleukin-8 secretion were used as measures of
LPS
responsiveness. Native colonic epithelial cells and IEC lines express a low level of TLR4 and
MD-2
mRNA. IFN-gamma regulates
MD-2
expression in both IEC lines, whereas IFN-gamma and TNF-alpha regulate TLR4 mRNA expression in IEC lines. Pre-incubation with IFN-gamma and/or TNF-alpha sensitizes IEC to
LPS
-dependent interleukin-8 secretion. To examine
MD-2
transcriptional regulation, we cloned a 1-kb sequence proximal to the
MD-2
gene translational start site. This promoter directed expression of a reporter gene in endothelial cells and IEC. IFN-gamma positively regulated
MD-2
promoter activity in IEC. Co-expression of a STAT inhibitor, SOCS3, blocked IFN-gamma-mediated
MD-2
promoter activation. T cell-derived cytokines lead to increased expression of TLR4 and
MD-2
and
LPS
-dependent pro-inflammatory cytokine secretion in IEC. IFN-gamma regulates expression of the critical TLR4 co-receptor
MD-2
through the Janus tyrosine kinase-STAT pathway. Th1 cytokines may initiate or perpetuate intestinal inflammation by altering toll-like receptor expression and bacterial reactivity.
...
PMID:TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. 1192 81
Members of the toll-like receptor family are crucial in recognition of microbial pathogens as part of innate immune response.
MD-2
, an accessory protein to TLR4, present on the extracellular side of the membrane is needed to initiate the signal transduction. We have identified a 15 amino acid region of human
MD-2
that contains several features of other
lipopolysaccharide
(
LPS
) binding proteins and peptides. In vitro
LPS
neutralization by this peptide was observed and confirmed by 2D transferred NOESY NMR experiments. NMR experiments have also shown binding of the
MD-2
peptide to lipoteichoic acid (LTA) but not to peptidoglycan. Furthermore this peptide inhibited growth of gram-negative and to a lower extent of some gram-positive bacteria. Our results indicate that this region of
MD-2
might be responsible for binding of
LPS
and confirms the role of
MD-2
as an accessory protein in
LPS
signaling bestowing the Toll receptors their specificity.
...
PMID:Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein. 1194 96
In human monocytes and macrophages, interferon-gamma (IFNgamma) augmented mRNA and surface expression of toll-like receptor 4 (TLR4), a crucial component of the signaling receptor complex for bacterial
lipopolysaccharide
(
LPS
). Expression of the accessory component
MD-2
and of the adapter protein MyD88 was also increased.
LPS
increased TLR4 mRNA levels, but concomitantly decreased its surface expression. IFNgamma counteracted the
LPS
-induced downregulation of TLR4. IFNgamma-primed monocytes showed increased responsiveness to
LPS
in terms of phosphorylation of the interleukin-1 receptor-associated kinase (IRAK; immediately downstream of the MyD88 adapter protein), NF-kB DNA binding activity, and, accordingly, of cytokine (tumor necrosis factor alpha [TNFalpha] and interleukin-12 [IL-12]) production. These results suggest that enhanced TLR4 expression underlies the long-known priming by IFNgamma of mononuclear phagocytes for pathogen recognition and killing as well as its synergism with
LPS
in macrophage activation.
...
PMID:Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. 1196 13
In order to mediate cellular response to
lipopolysaccharide
(
LPS
), Toll-like receptor (TLR) 4 must interact with
MD-2
, a secreted protein. In this study, a biochemical assay was developed to demonstrate that recombinant
MD-2
can interact with the extracellular portion of TLR4 in solution. The ability of
MD-2
to multimerize was confirmed, and MD-1 was also shown to possess this ability. Through site-directed mutagenesis, more than two intermolecular disulfide bonds were found to stabilize the
MD-2
multimer.
MD-2
's abilities to confer
LPS
responsiveness and to bind TLR4 were strongly associated functions. Remarkably, although the majority of recombinant
MD-2
exists in multimeric form, monomeric
MD-2
was found to preferentially bind TLR4 and to confer
LPS
responsiveness more efficiently than
MD-2
multimers.
...
PMID:Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. 1197 38
Endotoxin tolerance is characterized by a decreased production of proinflammatory cytokines by cultured leukocytes in response to
lipopolysaccharide
(
LPS
) following a first exposure to the same stimulus. Gamma interferon (IFNgamma) and granulocyte/monocyte colony-stimulating factor (GM-CSF) are immunostimulatory cytokines that prime monocytes and prevent endotoxin tolerance. In this study, we show that the deactivating effects of
LPS
, as well as the priming effects of IFNgamma and GM-CSF or their capacity to restore tumor necrosis factor (TNF) production by
LPS
-tolerized human monocytes are independent of the modulation of TLR2, TLR4, or
MD-2
. In monocytes pretreated with IFNgamma or GM-CSF, interleukin-1 receptor-associated kinase (IRAK) expression is up-regulated. After
LPS
stimulation, an increased IRAK kinase activity, a higher MyD88/IRAK association, and a stronger NF-kappaB activation are observed. In contrast, in
LPS
-tolerized monocytes, IRAK expression and kinase activity, IRAK/MyD88 association, and NF-kappaB activation are inhibited. Furthermore, the prevention of tolerance by IFNgamma and GM-CSF was independent of IRAK kinase activity. Our results suggest that these cytokines prevent endotoxin tolerance induced by low but not by high doses of
LPS
by inhibiting IRAK degradation and by promoting its association with MyD88 after a second
LPS
stimulation, which in turn leads to NF-kappaB activation and TNF production.
...
PMID:Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. 1203 43
Toll-like receptor 4 (TLR4) mediates
lipopolysaccharide
(
LPS
) signaling in a variety of cell types.
MD-2
is associated with the extracellular domain of TLR4 and augments TLR4-dependent
LPS
responses in vitro. We show here that
MD-2
(-/-) mice do not respond to
LPS
, do survive endotoxic shock but are susceptible to Salmonella typhimurium infection. We found that in
MD-2
(-/-) embryonic fibroblasts, TLR4 was not able to reach the plasma membrane and predominantly resided in the Golgi apparatus, whereas TLR4 was distributed at the leading edge surface of cells in wild-type embryonic fibroblasts. Thus,
MD-2
is essential for correct intracellular distribution and
LPS
-recognition of TLR4.
...
PMID:Essential role of MD-2 in LPS responsiveness and TLR4 distribution. 1205 29
The liver is an important site of host-microbe interaction. Although hepatocytes have been reported to be responsive to
lipopolysaccharide
(
LPS
), the global gene expression changes by
LPS
and mechanism(s) by which
LPS
stimulates cultured hepatocytes remain uncertain. Cultures of primary mouse hepatocytes were incubated with
LPS
to assess its effects on the global gene expression, hepatic transcription factors, and mitogen-activated protein (MAP) kinase activation. DNA microarray analysis indicated that
LPS
modulates the selective expression of more than 80 genes and expressed sequence tags. We have shown previously that hepatocytes express CD14, which is required both for uptake and responsiveness to
LPS
. In other cells, responsiveness to microbial products requires expression of Toll-like receptors (TLR) and their associated accessory molecules. Hepatocytes expressed TLR1 through TLR9 as well as MyD88 and
MD-2
transcripts, as shown by reverse transcriptase PCR analysis, indicating that hepatocytes express all known microbe recognition molecules. The MAP kinase extracellular signal-regulated kinase 1/2 was phosphorylated in response to
LPS
in mouse hepatocytes, and the levels of phosphorylation were lower in hepatocytes from TLR4-null mice. NF-kappa B activation was reduced in TLR4-mutant or -null hepatocytes compared to control hepatocytes, and this defect was partially restored by adenoviral transduction of mouse TLR4. Thus, hepatocytes respond to nanogram concentrations of
LPS
through a TLR4 response pathway.
...
PMID:Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. 1206 83
The alginate capsule produced by the human pathogen Pseudomonas aeruginosa is composed mainly of mannuronic acid polymers (poly-M) that have immunostimulating properties. Poly-M shares with
lipopolysaccharide
the ability to stimulate cytokine production from human monocytes in a CD14-dependent manner. In the present study we examined the role of Toll-like receptor (TLR) 2 and TLR4 in responses to poly-M. Blocking antibodies to TLR2 and TLR4 partly inhibited tumor necrosis factor production induced by poly-M in human monocytes, and further inhibition was obtained by combining the antibodies. By transiently transfecting HEK293 cells, we found that membrane CD14 together with either TLR2 or TLR4/
MD-2
could mediate activation by poly-M. Transfection of HEK293 cells with TLR2 and fluorescently labeled TLR4 followed by co-patching of TLR2 with an antibody revealed no association of these molecules on the plasma membrane. However, macrophages from the Tlr4 mutant C3H/HeJ mice and TLR4 knockout mice were completely non-responsive to poly-M, whereas the tumor necrosis factor release from TLR2 knockout macrophages was half of that seen with wild type cells. Taken together the results suggest that both TLR2 and TLR4 are involved in cell activation by poly-M and that TLR4 may be required in primary murine macrophages.
...
PMID:Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. 1208 42
Recognition by innate immune cells of the pathogen associated molecular patterns (PAMP)
lipopolysaccharide
(
LPS
) from Gram-negative bacteria and bacterial CpG-DNA depends on Toll-like receptor4 (TLR4) and TLR9, respectively. To define differences in the response to these distinct PAMP we compared a key intracellular event, namely recruitment of myeloid differentiation marker 88 (MyD88) to the respective PAMP-initiated TLR signaling. Using MyD88-GFP fusion protein expressing macrophages we demonstrate that
LPS
and CpG-DNA trigger signaling from two different cellular locations: theformer at the cell membrane and the latter at the lysosomal compartment. While
LPS
does not require endocytosis to functionally associate with the membrane expressed TLR4/
MD2
complex, internalization and endosomal maturation is conditional for CpG-DNA to activate TLR9. In support of these data TLR9 is not localized at the cell surface, but intracellularily. These data stress the need to characterize individual TLR at the very beginning of signal initiation in order to understand their diverse biological functions.
...
PMID:Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. 1211 16
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>